Preventable and curable infection caused by the bacterium Neisseria gonorrhoeae.
Increasing antimicrobial resistance to antibiotics have been observed in N. gonorrhoeae.
Currently, no vaccine is licensed for the prevention of gonorrhoea.
Sexually-transmitted infection.
Gonorrhoea causes different symptoms in women and men.
Most women with gonorrhea do not have symptoms or do not notice them. If left untreated, gonorrhoea can lead to infertility in both men and women and other sexual and reproductive health complications.
It also increases the risk of HIV infection.
In the EU/EEA region, there were over 70,000 cases of gonorrhoea in 2022.
In 2020 there were an estimated 82.4 million new infections among adults globally.
Generalised Modules for Membrane Antigens (1)
Phase II (1)
Paediatric + Adults (1)
Source:
WHO. Gonorrhoea (Neisseria gonorrhoeae infection). 2024. Available from: https://www.who.int/newsroom/fact-sheets/detail/gonorrhoea-(neisseria-gonorrhoeae-infection).
ECDC. Gonorrhoea – Annual Epidemiological Report for 2022. 2024 Available from: https://www.ecdc.europa. eu/en/publications-data/gonorrhoea-annual-epidemiological-report-2022.
[Accessed: August 2024]
